High performance libraries provide strong foundation for new developments to StarDrop drug discovery software. CAMBRIDGE, UK and SANTA FE, NEW MEXICO, USA – Optibrium™ and OpenEye Scientific (OpenEye), leading providers of software and services for drug discovery, today announced that StarDrop™, Optibrium’s software for small molecule design, optimisation and data analysis, is now powered by OpenEye […]
3decision® will enable Sosei Heptares to combine public and proprietary structural data and derive unique GPCR structural insights. Discngine, a software company specializing in developing applications for life sciences research, announces today that Sosei Heptares, an international biopharmaceutical group focused on G protein-coupled receptors (GPCRs), has selected its 3decision® software to be part of an […]
StarDrop™ and Augmented Chemistry™ prove a powerful combination in AI-guided design and validation of novel antimalarial drug candidates In silico designed compound demonstrates potency against pfATP4 protein target in malaria parasite CAMBRIDGE, UK – Optibrium™, leading providers of software and services for drug discovery, and Intellegens™, a spin-out from the University of Cambridge with a […]
NEW YORK– Schrödinger (Nasdaq: SDGR), whose physics-based software platform enables discovery of high-quality, novel molecules for therapeutics and materials, today announced an expanded collaboration with AstraZeneca focused on refining a biologics modeling solution with the aim of speeding up the development of antibody and protein-based therapeutic candidates. The multi-year agreement extends an existing collaboration in […]
Three-year deal will enable broader chemical exploration and accelerate advanced molecular modeling across internal and collaborative programs NEW YORK — Schrödinger, Inc. (Nasdaq: SDGR) today announced it has entered into a three-year agreement with Google Cloud to substantially increase the speed and capacity of its physics-based computational platform for drug discovery. As part of the […]
Tim Hohm to further develop Optibrium’s sales and business strategy for global market expansion CAMBRIDGE, UK – Optibrium™, a developer of software for drug discovery, today announced the appointment of Dr Tim Hohm as Director of Commercial Strategy and Business Development. Tim will be responsible for leading the Company’s commercial strategy and sales processes, with a […]
NEW YORK– Schrödinger, Inc. (the “Company”) (Nasdaq: SDGR), whose differentiated, physics-based software platform enables discovery of high-quality, novel molecules for drug development and materials applications, today announced the closing of its initial public offering of 13,664,704 shares of common stock at a public offering price of $17.00 per share, which includes 1,782,352 additional shares of […]
NEW YORK–Schrödinger, Inc. (the “Company”) (Nasdaq: SDGR), whose differentiated, physics-based software platform enables discovery of high-quality, novel molecules for drug development and materials applications, today announced the pricing of its initial public offering of 11,882,352 shares of common stock at a public offering price of $17.00 per share, for total gross proceeds of approximately $202.0 […]
NEW YORK — Schrödinger and Bayer (BAYN: DE) today announced a five-year technology alliance to develop a comprehensive de novo design solution with the objective to accelerate the discovery of innovative high-quality drugs. The technology is expected to be capable of enumerating, screening, and scoring billions of synthetically feasible, virtual compounds supporting the identification and optimization of […]
Partnership will advance both firms’ positions in the field of molecular dynamics-based drug discovery NEW YORK and SANTA FE, N.M. — Redesign Science and OpenEye Scientific are pleased to announce that they have entered into a strategic partnership to integrate OpenEye’s pioneering Orion computational platform into Redesign’s drug discovery platform. The practice of drug discovery has radically transformed […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
